Furosemide/Digoxin

呋塞米/地高辛

Report date: 2024/08/13 15:31:42

Base Information

Drug NameFurosemide/Digoxin

Drug Alias Name地高辛/呋塞米ICVTDigoxin/FrusemideIonic contra viral therapyFrusemide/Digoxin +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitorsSodium/potassium-transporting ATPase inhibitorsGamma-aminobutyric acid A receptor antagonists

TargetsSodium/potassium-transporting ATPaseGamma-aminobutyric acid A receptorSodium-(potassium)-chloride cotransporter 2

Therapy Area/IndicationsWarts

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsYes Digoxin Furosemide

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesCutanea

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMaruho Co Ltd

Active IndicationsN/A

Inactive IndicationsWarts

Other Information

ATC CodeN/A